MonoMethyl auristatin F
CAS No. 745017-94-1
MonoMethyl auristatin F ( Monomethyl auristatin F; MMAF )
Catalog No. M17587 CAS No. 745017-94-1
Monomethyl auristatin F, an antimitotic agent, inhibits cell division by blocking the polymerization of tubulin.
Purity : 98%
Size | Price / USD | Stock | Quantity |
2MG | 35 | In Stock |
|
5MG | 58 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 132 | In Stock |
|
50MG | 178 | In Stock |
|
100MG | 250 | In Stock |
|
200MG | 376 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMonoMethyl auristatin F
-
NoteResearch use only, not for human use.
-
Brief DescriptionMonomethyl auristatin F, an antimitotic agent, inhibits cell division by blocking the polymerization of tubulin.
-
DescriptionMonomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody. MMAF is actually desmethyl-auristatin F; that is, the N-terminal amino group has only one methyl substituent instead of two as in auristatin F itself.
-
SynonymsMonomethyl auristatin F; MMAF
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorCytotoxicity( Karpas 299 cell)
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number745017-94-1
-
Formula Weight731.98
-
Molecular FormulaC39H65N5O8
-
Purity98%
-
Solubility——
-
SMILESCC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC
-
Chemical Name((2R,3R)-3-((2S)-1-((3R,5S)-4-((S)-N,3-dimethyl-2-((S)-3-methyl-2-(methylamino)butanamido)butanamido)-3-methoxy-5-methylheptanoyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoyl)-L-phenylalanine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
TKIM
TKIM is a TWIK-related potassium channel 1 (TREK-1) inhibitor, binding to the pocket of the intermediate (IM) state of TREK-1.TKIM binds to the pocket of the IM state of TREK-1, which differs from the binding of common inhibitors, which bind to channels in the inactive state.?
-
Retigabine dihydroch...
Retigabine dihydrochloride is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients.?The mechanism of action involves opening of neuronal K(V)7.2-7.5 (formerly KCNQ2-5) voltage-activated K(+) channels.In differentiated PC12 cells, retigabine enhanced a linopirdine-sensitive current.?
-
VU 0134992
VU0134992 is an Kir4.1 blocker with an IC50 value of 0.97 μM.